These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28038988)

  • 1. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
    Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
    Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
    PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice.
    Lee JC; Jin Y; Jin J; Kang BG; Nam DH; Joo KM; Cha CI
    Neurol Res; 2011 Jan; 33(1):33-7. PubMed ID: 20810028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
    Hefferan MP; Galik J; Kakinohana O; Sekerkova G; Santucci C; Marsala S; Navarro R; Hruska-Plochan M; Johe K; Feldman E; Cleveland DW; Marsala M
    PLoS One; 2012; 7(8):e42614. PubMed ID: 22916141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1(G93A) ALS rats through neuroprotection and remyelination.
    Li Y; Bao J; Khatibi NH; Chen L; Wang H; Duan Y; Huang H; Zhou C
    Anat Rec (Hoboken); 2011 May; 294(5):847-57. PubMed ID: 21416627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis.
    Ohnishi S; Ito H; Suzuki Y; Adachi Y; Wate R; Zhang J; Nakano S; Kusaka H; Ikehara S
    Brain Res; 2009 Nov; 1296():216-24. PubMed ID: 19686706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Marcuzzo S; Bonanno S; Figini M; Scotti A; Zucca I; Minati L; Riva N; Domi T; Fossaghi A; Quattrini A; Galbardi B; D'Alessandro S; Bruzzone MG; García-Verdugo JM; Moreno-Manzano V; Mantegazza R; Bernasconi P
    Exp Neurol; 2017 Jul; 293():43-52. PubMed ID: 28351750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.